Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-128060
Filing Date
2021-10-20
Accepted
2021-10-20 16:09:32
Documents
1
Period of Report
2021-10-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2130633-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2130633-6_4seq1.xml 4 5429
  Complete submission text file 0001104659-21-128060.txt   6895
Mailing Address C/O ALBIREO PHARMA, INC. 50 MILK STREET, 16TH FLOOR BOSTON MA 02109
Business Address
Gutch Michael (Reporting) CIK: 0001687333 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 211334146

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Issuer) CIK: 0001724344 (see all company filings)

EIN.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations